Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Akebia, Biontech, Celltrion Healthcare, Eli Lilly, Iaso, Innovent Biologics, Johnson & Johnson, Lannett Co., Micurx, Moderna, Neuren, Neurorx, Otsuka, Pfizer, Regeneron, Respirent, Visen.